Adicet Bio (ACET) News
NASDAQ: ACETHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ACET news summary
We found 2 recent headlines mentioning Adicet Bio (ACET): 0 in the past week and 1 in the past 30 days, most often from Business Wire, Nasdaq. ACET is making an outsized move today, down 13.01% at $2.14, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Adicet Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates", was published by Business Wire on Nov 5, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Adicet Bio headlines
- Adicet Bio Reports Third Quarter 2026 Financial Results and Provides Business UpdatesREDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies…Business Wire
- Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year?Here is how Tenet Healthcare (THC) and Adicet Bio, Inc. (ACET) have performed compared to their sector so far this year.NasdaqTHC, ACET